Abstract
BackgroundSevere acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) is an emerging viral pandemic disease. In the last 6 months, SARS-CoV-2 has caused millions of reported cases and hundreds of thousands of deaths. As other world regions, South America has not contained the pandemic’s advance since it lacks the hospital and economic capacities. Public health implications of transmission, while the asymptomatic/presymptomatic infection is a critical concern at the current pandemic.ObjectiveDescribe the socio-demographic, clinical, and viral features of a cohort of SARS-CoV-2 infected individuals from the Colombian Caribbean.MethodsSix hundred eighty-six clinical samples of suspected SARS-CoV-2 infection cases and contacts individuals from several hospital centers in the department of Córdoba, Colombia, were received at our laboratory between April 9th and May 16th, 2020. RNA was extracted using lysis buffers and spin columns. The samples were tested for SARS-CoV-2 by reverse transcription real-time polymerase chain reaction (RT-qPCR) using commercially available multiplex real-time PCR assay for simultaneous detection of 3 target genes of SARS-CoV-2 (Allplex™, 2019-nCoV assay, Korea). Viral copies quantification was done using a standard curve constructed from seriated dilutions of a SARS-CoV-2 positive control. Statics descriptive methods were used.ResultsThirty-five nasopharyngeal samples were positive for SARS-CoV-2 infection; the average age was 43 (range, 1–95 years). Seventeen of 35 (49%) of the patients showed symptoms. Most of them had a cough, fever, and odynophagia; three of the patients reported having arthralgia. Only two patients required hospitalization. None of the patients had known co-morbidities. RT-qPCR results show that two of the symptomatic patients had significantly higher RNA copies than the rest. Eighteen of 35 (51%) individuals were asymptomatic, and the average age was 30 (range, 6–61 years). Four asymptomatic individuals showed a higher copy than some symptomatic patients; nonetheless, the average of RNA copies 8.26 × 1010 was lower than the symptomatic.ConclusionsThis study shows that asymptomatic patients may develop infections with a high number of RNA copies. Since a considerable percentage of infections may be asymptomatic/presymptomatic, enhanced testing approaches may be needed to detect these persons. Due the occurrence of a large proportion of infections being a result from transmission originated in asymptomatic/presymptomatic individuals, public health interventions in Colombia should be based on two steps: a massive molecular screening, and viral load quantification. Finally, a remarkable issue in our study is the average age of symptomatic and asymptomatic groups (43 and 30 respectively) which may be important because of the economic impact that has been caused by the coronavirus pandemic and may be probably the cause of the reduced lethality observed in the country and the department at the time of this study.
Highlights
Coronavirus disease 2019 (COVID-19), caused by Severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2), is an emerging viral disease that has caused millions of reported cases and hundreds of thousands of deaths in the last 6 months
Thirty-five nasopharyngeal samples were positive for SARS-CoV-2 infection; the average age was 43
This study shows that asymptomatic patients may develop infections with a high number of RNA copies
Summary
Coronavirus disease 2019 (COVID-19), caused by Severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2), is an emerging viral disease that has caused millions of reported cases and hundreds of thousands of deaths in the last 6 months. Nowadays, South America has not contained the pandemic’s advance since it lacks the hospital and economic capacities, reporting more than nine million of infected people, being the top six countries’ distribution as follows: Brazil has 5,224,362 cases, Argentina 979,119, Colombia 952,371, Peru 865,549, Chile 490,003, and Ecuador 152,422 cases [1]. Severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) is an emerging viral pandemic disease. In the last 6 months, SARS-CoV-2 has caused millions of reported cases and hundreds of thousands of deaths. Public health implications of transmission, while the asymptomatic/presymptomatic infection is a critical concern at the current pandemic
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have